Terminal differentiation in neuroblastoma cells transfected with the NGF receptor gene when treated with NGF.
Matsushima
H
H
Department of Pathology, Childrens Hospital of Los Angeles, California 90027.
Bogenmann
E
E
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D006801:Humans; D007700:Kinetics; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009447:Neuroblastoma; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000235:genetics; D016760:Proto-Oncogene Proteins c-fos; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis; D011519:Proto-Oncogenes / Q000187:drug effects; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D017475:Receptors, Nerve Growth Factor; D014162:Transfection
D009414:Nerve Growth Factors; D011518:Proto-Oncogene Proteins; D016760:Proto-Oncogene Proteins c-fos; D016271:Proto-Oncogene Proteins c-myc; D011956:Receptors, Cell Surface; D017475:Receptors, Nerve Growth Factor; D011505:Protein-Tyrosine Kinases